PlainPharmaWatch

CMS Open Payments · Program Year 2024

Galvanize Therapeutics, Inc

Galvanize Therapeutics, Inc reported $2,674,389.15 in payments to 830 physicians and teaching hospitals across 956 transactions.

See the rankings → How this is sourced
$2.7M
Total payments
956
Transactions
830
Recipients
+$130.7K
General Payments vs PY2023

Galvanize Therapeutics, Inc reported $2,674,389.15 in payments to 830 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #390 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $3.2K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Galvanize Therapeutics, Inc pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#390
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Galvanize Therapeutics, Inc's CMS-reported General Payments increased by $130.7K (+134.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: GALVANIZE THERAPEUTICS, INCPY2023: GALVANIZE THERAPEUTICS, INCPY2024: Galvanize Therapeutics, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$97.5KPY2024$228.2K
PY2023
$97,478.51
PY2024
$228,170.34

How Galvanize Therapeutics, Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Galvanize Therapeutics, Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,674,389 Top 20% higher than 80% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Galvanize Therapeutics, Inc

Rank #390 of 1,925 companies in CMS Open Payments for 2024 belongs to Galvanize Therapeutics, Inc, which reported $2,674,389.15 across 956 transactions to 830 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $2.8K per transaction and $3.2K per recipient.

Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $151.0K across 39 transactions, 5.6% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Galvanize Therapeutics, Inc made 4 types of general payments. "Consulting Fee" is the largest category at $151.0K, 5.6% of the company's reported total.

How Galvanize Therapeutics, Inc divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$151.0K2. Food and Beverage$67.5K3. Travel and Lodging$8.7K4. Entertainment$1.0K
Payment Type Amount Transactions
Consulting Fee $151.0K 39
Food and Beverage $67.5K 763
Travel and Lodging $8.7K 20
Entertainment $1.0K 8

Recipient Concentration in General Payments

The five largest recipient relationships account for $139,288.33 (61.0%) of $228,170.34 in this company's General Payments records across 556 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Galvanize Therapeutics, Inc

The five named recipients with the highest reported General Payments from this company

Joseph Mammarappallil$59.7KWilliam Moore$33.3KRobert Suh$19.3KMichael Pritchett$18.4KJoseph Whitlark$8.6K
  1. 1

    Joseph Mammarappallil

    $59,716.65 across 60 reported transactions

  2. 2

    William Moore

    $33,272.01 across 14 reported transactions

  3. 3

    Robert Suh

    $19,308.93 across 4 reported transactions

  4. 4

    Michael Pritchett

    $18,404.43 across 8 reported transactions

  5. 5

    Joseph Whitlark

    $8,586.31 across 10 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $2.8K. Average per recipient: $3.2K.

Total Amount

$2,674,389.15

Avg per Transaction

$2.8K

Avg per Recipient

$3.2K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Galvanize Therapeutics, Inc Share

0.0%

#390 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Galvanize Therapeutics, Inc

Calyxo, Inc.

$2.7M 1,299 recipients

CVRx, Inc.

$2.7M 16,025 recipients

Vertical Orthopaedics, Inc.

$2.7M 19 recipients

Global Blood Therapeutics, Inc.

$2.7M 0 recipients

Nanovis LLC

$2.7M 24 recipients

Ardelyx, Inc.

$2.6M 42,247 recipients

Frequently Asked Questions

How much did Galvanize Therapeutics, Inc pay to physicians and hospitals in 2024? ▾
Galvanize Therapeutics, Inc made $2,674,389.15 in payments to physicians and hospitals in Program Year 2024, across 956 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Galvanize Therapeutics, Inc? ▾
Averaging $3.2K per recipient, Galvanize Therapeutics, Inc's 2024 payments reached 830 physicians and teaching hospitals.
What types of payments did Galvanize Therapeutics, Inc make? ▾
General payments from Galvanize Therapeutics, Inc span 4 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $151.0K, representing 5.6% of the company's reported total.
How does Galvanize Therapeutics, Inc rank among pharmaceutical companies? ▾
By total payment amount, Galvanize Therapeutics, Inc sits at #390 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Galvanize Therapeutics, Inc? ▾
The average transaction from Galvanize Therapeutics, Inc was $2.8K in 2024. The company made 956 total transactions to 830 recipients.
Where does the payment data for Galvanize Therapeutics, Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Galvanize Therapeutics, Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.